ZONTIVITY (Aralez Pharmaceuticals Us Inc.)
Welcome to the PulseAid listing for the ZONTIVITY drug offered from Aralez Pharmaceuticals Us Inc.. This Protease-activated Receptor-1 Antagonist [EPC],Protease-activated Receptor-1 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aralez Pharmaceuticals Us Inc. |
| NON-PROPRIETARY NAME: | vorapaxar |
| SUBSTANCE NAME: | VORAPAXAR SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Protease-activated Receptor-1 Antagonist [EPC],Protease-activated Receptor-1 Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-05-08 |
| END MARKETING DATE: | 0000-00-00 |
ZONTIVITY HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZONTIVITY from Aralez Pharmaceuticals Us Inc. |
| LABELER NAME: | Aralez Pharmaceuticals Us Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.08(mg/1) |
| START MARKETING DATE: | 2014-05-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70347-208_708f0d47-bd22-483a-8925-c4795bd93f8b |
| PRODUCT NDC: | 70347-208 |
| APPLICATION NUMBER: | NDA204886 |
Other VORAPAXAR SULFATE Pharmaceutical Manufacturers / Labelers:
